| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0707485A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121355A Variants of bile salt-stimulated lipase, DNA molecules encoding them, and transgenic non-human mammals |
| 04/24/1996 | CN1121348A Indole derivatives as 5-H1-like agonists for use in migraine |
| 04/23/1996 | US5510488 Chemical intermeidates |
| 04/23/1996 | US5510376 Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents |
| 04/23/1996 | US5510370 Osteoporosis, osteoarthritis treatment |
| 04/23/1996 | US5510365 Suppression of tumor necrosis factor (tnfalpha) activity |
| 04/23/1996 | US5510360 Administering orally, side effect reduction |
| 04/23/1996 | US5510342 Method of lowering cholesterol |
| 04/23/1996 | US5510340 Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use |
| 04/23/1996 | US5510335 Pre-exercise hydration with a glycerol solution |
| 04/23/1996 | US5510263 Growth of pancreatic islet-like cell clusters |
| 04/23/1996 | US5510250 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 04/19/1996 | CA2160753A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/18/1996 | WO1996011268A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011200A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | WO1996011196A1 Pyrazolylmethyl-thiazolidines useful as hypoglycemic agents |
| 04/18/1996 | WO1996011195A1 Indole derivatives as 5ht1-like agonists |
| 04/18/1996 | WO1996011015A1 Hydration compositions for human or animal bodies |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | CA2201773A1 Purine and guanine compounds as inhibitors of pnp |
| 04/18/1996 | CA2196991A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 04/17/1996 | EP0706793A2 Use of phthalidyliden esters of carnitine and alkanoyl carnitines for the treatment of endotoxic shock |
| 04/17/1996 | EP0706657A1 Inhibiting protein interactions |
| 04/17/1996 | EP0706508A1 Anti-atherosclerotic diaryl compounds |
| 04/17/1996 | EP0706399A1 Compositions and process for removing bile salts |
| 04/17/1996 | EP0568594B1 NOVEL INSULIN ANALOGS suited for transdermal application |
| 04/17/1996 | CN1120843A 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 04/17/1996 | CN1031570C Process for preparation of pyrazolopyridine compound |
| 04/17/1996 | CN1031564C Process for preparation of 4-|-(2-hydroxy-2-phenylethylamino)ethoxy¨ phenyl acet acid and its derivatives |
| 04/16/1996 | US5508392 Use of vitamin D glycosides, vitamin D orthoester glycosides, vitamin D analog glycosides and vitamin D analog orthoester glycosides for the treatment of osteoporosis |
| 04/16/1996 | US5508391 Nonhygroscopic, free-flowing, stable, water soluble |
| 04/16/1996 | US5508274 24R,25-dihydroxycholecalciferol to treat vitamin D resistant rickets |
| 04/16/1996 | US5508260 Mixtures of insulin and calcitonin which can promote uniform blood glucose concentration |
| 04/11/1996 | WO1996010629A1 The irs family of genes |
| 04/11/1996 | WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 04/11/1996 | WO1996010574A1 Method for preparing concentrated biologically active silicon compounds |
| 04/11/1996 | WO1996010559A1 Urea derivatives and their use as acat-inhibitors |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | CA2201474A1 The irs family of genes |
| 04/11/1996 | CA2200981A1 Urea derivatives and their use as acat-inhibitors |
| 04/10/1996 | EP0705839A1 Imidobisphosphoric acids, process for their preparation and their use |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705831A2 Cycloalkano-indole- and -azaindole derivatives |
| 04/10/1996 | EP0705607A2 Condensed seven- or eight-membered heterocyclic compounds useful as antihypertriglyceridemic agents |
| 04/10/1996 | EP0705275A1 Asp?b28 insulin crystals |
| 04/10/1996 | EP0705100A1 Therapeutic substituted guanidines |
| 04/10/1996 | CN1120314A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1120304A Method and composition for treatment of osteoporosis |
| 04/10/1996 | CN1119940A Combination treatment for inhibiting bone loss |
| 04/09/1996 | US5506243 Sulfonamide derivatives |
| 04/09/1996 | US5506229 Skeletal and muscle disorders |
| 04/09/1996 | US5506218 Intravenously administering a protein and peptide free phospholipid and neutral lipid to the subject; prophylaxis |
| 04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
| 04/08/1996 | CA2160092A1 Antihypertriglyceridemic composition |
| 04/08/1996 | CA2159938A1 Oxime derivatives, their preparation and their therapeutic use |
| 04/04/1996 | WO1996010033A1 Sterol compositions from pulping soap |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996009819A1 Inhibitor for bone resorption by osteoclast |
| 04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
| 04/04/1996 | CA2201328A1 Sterol compositions from pulping soap |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0458861B1 Composition for reparation and prevention of fibrotic lesions |
| 04/03/1996 | CN1119650A Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 04/03/1996 | CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 04/02/1996 | US5504115 Inhibitors of farnesyl protein transferase |
| 04/02/1996 | US5504094 Use of bengothiophenls to treat pain due to an excess of neuropeptide y |
| 04/02/1996 | US5503831 Foodstuff; obesity treatment |
| 03/28/1996 | WO1996009317A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | WO1996009287A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009042A1 Compositions and methods for the control of smoking |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200755A1 Compositions and methods for the control of smoking |
| 03/28/1996 | CA2200472A1 Novel heterocyclic derivatives, method of prodution thereof and pharmaceutical use thereof |
| 03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | CA2200354A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
| 03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
| 03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
| 03/27/1996 | EP0702954A2 Calcium dietary supplement |
| 03/27/1996 | EP0702903A1 Process for producing fat- and cholesterol-reduced egg-based powdery products of high phospholipid content |
| 03/27/1996 | EP0702692A1 Regulation of antigen presentation |
| 03/27/1996 | EP0548250B1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
| 03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
| 03/27/1996 | CA2158811A1 Calcium dietary supplement |
| 03/26/1996 | US5502216 Anticholesterol |
| 03/26/1996 | US5502198 α-aryl or heteroaryl-substituted amide ester ACAT inhibitors |
| 03/26/1996 | US5502077 Fatty acid composition |
| 03/26/1996 | US5502060 HIV protease inhibitors |
| 03/26/1996 | US5502045 Use of a stanol fatty acid ester for reducing serum cholesterol level |
| 03/26/1996 | US5501861 Carbohydrates |
| 03/26/1996 | CA1338185C Glycosidase inhibitor salbostatin, process for its preparation, and its use |